JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
Standard
JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. / Schnittger, S; Bacher, Ulrike; Kern, W; Haferlach, C; Haferlach, T.
In: LEUKEMIA, Vol. 21, No. 1, 1, 2007, p. 183-184.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Schnittger, S, Bacher, U, Kern, W, Haferlach, C & Haferlach, T 2007, 'JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.', LEUKEMIA, vol. 21, no. 1, 1, pp. 183-184. <http://www.ncbi.nlm.nih.gov/pubmed/17096014?dopt=Citation>
APA
Schnittger, S., Bacher, U., Kern, W., Haferlach, C., & Haferlach, T. (2007). JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. LEUKEMIA, 21(1), 183-184. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17096014?dopt=Citation
Vancouver
Schnittger S, Bacher U, Kern W, Haferlach C, Haferlach T. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. LEUKEMIA. 2007;21(1):183-184. 1.
Bibtex
@article{88f4bf76e3324cd1922293060f596796,
title = "JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.",
author = "S Schnittger and Ulrike Bacher and W Kern and C Haferlach and T Haferlach",
year = "2007",
language = "Deutsch",
volume = "21",
pages = "183--184",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "1",
}
RIS
TY - JOUR
T1 - JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
AU - Schnittger, S
AU - Bacher, Ulrike
AU - Kern, W
AU - Haferlach, C
AU - Haferlach, T
PY - 2007
Y1 - 2007
M3 - SCORING: Zeitschriftenaufsatz
VL - 21
SP - 183
EP - 184
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 1
M1 - 1
ER -
